We are live on ! Find out more
IQMDU

Intelligent Medicine Acquisition Corp. Unit
IQMDU

Delisted

IQMDU was delisted on the 26th of April, 2023.

Back to rankings

26 hedge funds and large institutions have $42.1M invested in Intelligent Medicine Acquisition Corp. Unit in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 6 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% less funds holding

Funds holding: 64 → 26 (-38)

66% less capital invested

Capital invested by funds: $123M → $42.1M (-$80.5M)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 39

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 6

Holders
26
Holders Change
-38
Holders Change %
-59.38%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
6
Closed
39
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
-$10.2M
2
PC
Periscope Capital
Ontario, Canada
-$7.17M
3
LA
Linden Advisors
New York
-$7.14M
4
SC
Sculptor Capital
New York
-$5.1M
5
CSS
Cubist Systematic Strategies
Connecticut
-$4.47M

IQMDU Hedge Fund Activity: Q1 2022 in Review

26 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Unit (IQMDU) for Q1 2022, worth a combined $42.1M — down 66% from $123M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of IQMDU and 1 opened new positions — a net loss of 38 holders — while 6 trimmed existing stakes and 0 added.

The largest seller was MMCAP International, exiting entirely with an estimated $10.2M sold.

  • 26 institutional investors held Intelligent Medicine Acquisition Corp. Unit (IQMDU) as of Q1 2022, down from 64 in Q4 2021.
  • Funds reported $42.1M of Intelligent Medicine Acquisition Corp. Unit stock for Q1 2022, down 66% quarter-over-quarter.
  • 1 fund opened new Intelligent Medicine Acquisition Corp. Unit positions in Q1 2022 and 39 closed out, a net change of -38 holders.
  • The largest Intelligent Medicine Acquisition Corp. Unit seller in Q1 2022 was MMCAP International, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2022.